Meet us at AACR
The AACR Annual Meeting is the focal point of the cancer research community. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Meeting highlights the work of the best minds in cancer research from institutions all over the world. Joe F. Donahue, our Chief Business Officer […]
Colin Hill to Speak at The Longwood Healthcare Leaders Winter Webconference
On Thursday, January 6, Colin Hill, will be moderating a panel on Expediting Research for Treatments and Cures at the Longwood Healthcare Leaders winter webconference. He will be joined by Christopher Coburn, CIO, Mass General Brigham; Ray Deshaies, SVP, Research, Amgen; Raj Devraj, CEO, Rectify Pharma; Brian McVeigh, CEO, Code Biotherapeutics and Chen Schor, Chair, […]
Genentech oncology collaboration with GNS featured in TechEmergence
October 11, 2017 by Jon Walker Genentech, a member of the Roche Group, this summer announced their own collaboration with Cambridge, MA-based GNS Healthcare. GNS Healthcare’s mission statement is to use the latest innovations in machine learning to turn biomedical data into solutions and treatments. This collaboration’s first focus will also be on oncology, just like the IBM/Pfizer deal. Genentech […]
GNS Taps Nationally Regarded Epidemiologist to Put Discoveries From Causal Machine Learning and Simulation Platform in ‘Clinical Context’
Veteran Healthcare Leader Julie Slezak Appointed to Executive Vice President of Clinical Analytics CAMBRIDGE, Mass. – April 4, 2017 – Leading precision medicine company GNS Healthcare (GNS) today announced that nationally regarded epidemiologist and biostatistician Julie Slezak has been named to the newly created position Executive Vice President of Clinical Analytics. Slezak, who previously headed […]
GenomeWeb Article Offers Insight on GNS-Celgene Deal and Growing Demand for Causal Modeling
GNS Healthcare and Celgene have signed a service and license arrangement that allows the biopharma firm to use GNS Healthcare’s causal machine-learning and simulation platform for applications in drug discovery, clinical development, and commercialization and market access. Read the full story here.
GNS Healthcare Applauds Precision Medicine Initiative
Big Data-Driven Effort Has Potential to Improve Health Outcomes, Save $100Bs CAMBRIDGE, Mass. – Feb. 2, 2015 – GNS Healthcare (GNS), a leading provider of analytics solutions for driving personalized interventions that improve population health, issued the following statement by its CEO and co-founder, Colin Hill. The statement follows Hill’s participation Friday at a White […]
GNS Healthcare Adds Two Leading Experts to Scientific Advisory Board
Dr. Richard Popiel and Dr. Atul Butte to Assist GNS as it Applies Machine Learning to Population Health Strategies CAMBRIDGE, Mass. – Dec. 17, 2014 – GNS Healthcare (GNS), a leading provider of analytics solutions for driving personalized interventions that improve population health, today announced the addition of Richard Popiel, MD, MBA and Atul Butte, […]